Bavarian Nordic inks new Ebola contract

Deal could end up generating income of up to 220 million kroner

The Danish biotech company Bavarian Nordic has signed a contract with its Dutch counterpart Crucell Holland BV to produce a vaccine against Ebola.

Crucell Holland BV is a subsidiary of Belgian-based Janssen Pharmaceutical Companies, which in turn is a subsidiary of Johnson & Johnson.

The contract, worth an estimated 60 million kroner, involves the development and production of a prime-boost vaccine against Ebola consisting of Bavarian Nordic’s MVA-BN® Filo and Janssen’s Ad26.ZEBOV.

“We are very pleased to strengthen our collaboration with Janssen on the accelerated development of the prime-boost Ebola vaccine regimen,” said Paul Chaplin, the president and CEO of Bavarian Nordic.

“More importantly, it is encouraging that the US government – through BARDA, with whom we have worked for over a decade – recognises the potential of this vaccine to build international preparedness for current and future Ebola outbreaks.”

READ MORE: Bavarian Nordic storms ahead with half-year results

Promising trials
The contract will initially span five years, but it includes options for further deals that could be worth about 160 million kroner.

As part of an accelerated development program, Janssen has already launched a series of clinical tests of the prime-boost vaccine in Europe and Africa.

Bavarian Nordic has not altered its financial expectations for the year as most of the income generated by the deal won’t be realised until 2016 and 2017.




Connect Club is your gateway to a vibrant programme of events and an international community in Denmark.


  • “It’s possible to lead even though you don’t fit the traditional leadership mold”

    “It’s possible to lead even though you don’t fit the traditional leadership mold”

    Describing herself as a “DEI poster child,” being queer, neurodivergent and an international in Denmark didn’t stop Laurence Paquette from climbing the infamous corporate ladder to become Marketing Vice President (VP) at Vestas. Arrived in 2006 from Quebec, Laurence Paquette unpacks the implications of exposing your true self at work, in a country that lets little leeway for individuality

  • Deal reached to bring more foreign workers to Denmark

    Deal reached to bring more foreign workers to Denmark

    Agreement between unions and employers allows more foreign workers in Denmark under lower salary requirements, with new ID card rules and oversight to prevent social dumping and ensure fair conditions.

  • New association helps international nurses and doctors Denmark

    New association helps international nurses and doctors Denmark

    Kadre Darman was founded this year to support foreign-trained healthcare professionals facing challenges with difficult authorisation processes, visa procedures, and language barriers, aiming to help them find jobs and contribute to Denmark’s healthcare system